Trade Mark Journal No.2024/040 4 October 2024

WO0000001810761 (1,5,42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:18 April 2024
Date of designation in the UK: 18 April 2024
Image for mark 1810761_TIF Eximmium

International priority date claimed: 23 October 2023 (European Union Intellectual Property Office (EUIPO)) (018940550)
Class 1
Chemical substances, materials and preparations for industrial purposes; chemical compositions and materials for use in science; chemical components for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; tagged antibodies for scientific use; immunological antibodies, other than for medical use; monoclonal antibodies for diagnostic use [other than medical]; antibodies for scientific purposes, other than for medical or veterinary use; diagnostic preparations for scientific purposes; diagnostic preparations for scientific purposes; clinical diagnostics, other than for medical or veterinary use; diagnostic reagents for in-vitro use [other than medical]; diagnostic reagents, other than for medical use for sale in kit form.
Class 5
Medical and veterinary preparations; pharmaceuticals and natural remedies; biotechnological preparations for medical use; antibodies; diagnostic agents for medical use; diagnostic preparations and materials; diagnostic agents for pharmaceutical use; diagnostic preparations; anti-cancer drugs; compounds for treating cancer; pharmaceutical preparations and substances for use in oncology; clinical diagnostic reagents.
Class 42
Science and technology services; natural science services; medical and pharmacological research services; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to biotechnology; research relating to biotechnology; research relating to biotechnology; biotechnology testing; research relating to biotechnology; research relating to biotechnology; research and development in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibody technology; research and development services in the field of antibodies; laboratory services relating to the production of monoclonal antibodies; research and development in the field of diagnostic preparations.
Class 44
Human healthcare services; animal healthcare services; medical services; medical and healthcare services; human hygiene and beauty care; advisory services relating to medical services; medical services in the field of oncology; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical diagnostic services.

Eximmium Biotechnologies GmbH

Representative: SCHIWECK WEINZIERL KOCH PATENTANWÄLTE PARTNERSCHAFT MBB, Ganghoferstrasse 68b, 80339 München, GERMANY